HCP Plastene Bulkpack Ltd reported consolidated revenue of Rs 217.25 crore for Q2 FY27, up from Rs 197.70 crore in the same period last year. Net profit rose to Rs 9.76 crore against Rs 4.99 crore in Q2 FY26. The company also announced a change in finance leadership with Mr. Aman Prakash Parekh taking over as CFO from Mr. Prakash Hiralal Parekh, who remains Managing Director. Additionally, the Board approved the grant of 140,100 ESOPs to eligible employees.
HCP Plastene Bulkpack Reports Q2 Profit Growth and Leadership Shuffle
Q2 Revenue stood at Rs 217.25 crore with a Net Profit of Rs 9.76 crore.
Reader Takeaway: Strong year-on-year growth provides stability, while finance leadership transition marks a strategic shift for the company.
What just happened
HCP Plastene Bulkpack Ltd has released its financial results for the quarter ended September 30, 2026, alongside key management updates. The company achieved a consolidated revenue of Rs 217.25 crore, marking a steady increase from Rs 197.70 crore in the year-ago period. Net profit for the quarter stands at Rs 9.76 crore, nearly double the Rs 4.99 crore reported in Q2 FY26. Diluted EPS for the quarter is Rs 9.18.
Why this matters
The company is undergoing a leadership transition within its finance department. Mr. Prakash Hiralal Parekh has resigned as CFO effective November 6, 2026, though he will continue in his role as Managing Director. Mr. Aman Prakash Parekh has been appointed as the new CFO and redesignated from Whole-time Director to Executive Director. Stability in the finance function is critical for maintaining investor confidence during executive transitions.
ESOP Grant
The Board has approved an ESOP grant of 140,100 options under the company's 2022 scheme. These options are priced at Rs 10 per share and are exercisable within five years from the vesting date. This initiative is aimed at talent retention and incentivizing key staff as the company grows.
What to track next
Investors should observe the operational direction taken by the newly appointed CFO and monitor if the year-on-year revenue growth trajectory is sustained in the coming quarters. The impact of the recent management changes on financial oversight remains a point of interest for long-term shareholders.
